Table 1 Characteristics of 117 patients with hepatic veno-occlusive disease at the time of diagnosis
From: Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study
Characteristic | Obtained data |
|---|---|
Age (years) | 63.0 (52.5–69.0) |
Male/female (%) | 67/33 |
Clinical manifestations, n (%) | |
Ascites | 116 (99.1) |
Abdominal distention | 115 (98.3) |
Poor appetite | 48 (41.0) |
Nausea, vomiting | 19 (16.2) |
Malaise | 39 (33.3) |
Lower limb oedema | 46 (39.3) |
Hepatomegaly | 82 (70.0) |
Splenomegaly | 40 (34.2) |
Right upper quadrant pain | 23 (19.7) |
Weight gain | 21 (18.0) |
Encephalopathy | 19 (16.2) |
Variceal bleeding | 3 (2.6) |
Laboratory tests | |
WBC (109/L) | 6.1 (5.0–8.7) |
RBC (1012/L) | 4.4 (3.9–4.9) |
PLT (109/L) | 113 (78–153) |
ALT (U/L) | 49.0 (25.0–152.5) |
AST (U/L) | 75.0 (39.0–158.5) |
GGT (U/L) | 100.7 (61.8–164.8) |
ALP (U/L) | 122.0 (86.8–191.3) |
TB (μmol/L) | 33.3 (19.7–47.0) |
DB (μmol/L) | 21.5 (12.7–30.5) |
ALB (g/L) | 30.6 (27.7–33.6) |
PT (s) | 14.8 (12.7–17.0) |
BUN (mmol/L) | 5.5 (3.8–7.9) |
CR (μmol/L) | 74.0 (60.0–90.0) |
CA-125 (U/ml) | 259.9 (182.1–458.4) |
CA199 | 13.04 (7.9–34.2) |
Treatment, n (%) | |
Non-anticoagulation | 26 (22.2) |
Anticoagulation | 74 (63.2) |
Anticoagulation + TIPS | 17 (14.5) |